FDA-cleared radiology AI devices rose by 42% between 2023 and 2025, now totaling over 1,000 approved tools.
Key Details
- 1Analysis published in Academic Radiology reviews FDA's AI-enabled device database.
- 21,094 radiology-specific AI devices authorized by FDA through December 2025.
- 3Annual authorizations for radiology AI rose by 42% from 2023 to 2025.
- 4Radiology remains the leading field for FDA-cleared AI medical devices.
- 5Device functions, clinical applications, and regulatory profiles were categorized by the study team.
Why It Matters
Rapid growth in FDA-cleared AI radiology devices signals increasing market availability, influencing procurement and clinical integration strategies. Updated regulatory insights support informed decision-making and point to ongoing areas for research and development.
Source
Radiology Business
Related News
•Radiology Business
Vara's AI Gains World's First Approval for Radiologist-Free Mammogram Triage
Vara has secured the world's first regulatory approval for an AI tool that autonomously classifies certain mammograms as normal, bypassing radiologist review.
•AuntMinnie
Vast Majority of FDA-Cleared Radiology AI Devices Lack Outcome Trials
Only 0.3% of FDA-cleared radiology AI devices have registered trials on patient outcomes, raising concerns about evidence standards.
•Radiology Business
Radiology Partners Urges FDA for Clarity on Imaging AI Regulations
Radiology Partners and Mosaic Clinical Technologies petition the FDA for clearer regulatory guidelines on imaging AI vision-language models.